#	Pagina
attuale pagina	/open-h2020/projects/224504/index.html
-1	/open-h2020/projects/210137/index.html
-2	/open-h2020/per-topic/ansd/list/index.html
-3	/open-h2020/per-topic/homogenizer/list/index.html
-4	/open-h2020/per-topic/toxrisk/list/index.html
-5	/open-h2020/projects/194398/deliverables.html
-6	/open-h2020/per-topic/flashmob/list/index.html
-7	/open-h2020/per-topic/progressing/list/index.html
-8	/open-h2020/per-topic/digiman4/list/index.html
-9	/open-h2020/projects/225018/deliverables.html
-10	/open-h2020/per-topic/fpgas/list/index.html

Opendata, web and dolomites

SIGUEMED SIGNED

The first affordable and easy-to-use IoT system that tracks pill intake with printed circuits technology

Total Cost €

EC-Contrib. €

Partnership

Views

SIGUEMED project word cloud

Explore the words cloud of the SIGUEMED project. It provides you a very rough idea of what is the project "SIGUEMED" about.

meet treatment deaths associate authorized platform additional reports demands poly premature intake wearables distributors first pharmacies 00 people hospitalisations provides disruptive eu28 siguemed alerts shape connected medical remind cascade base pharmacists none commercialization monthly correct blister countries heavy medicated sufficient reached printed pack records chronic network economic burden sw 125 solution ehealth place dock breach sent sale world 350 roi pills convenient create immigrants solutions contact market foil attempt citizens circuits combining services digital penetration medication personalized patients caretaker extra iot time smart relatives bridge massive commercialize unsolved track monitoring clients societal 200 gap bluetooth adherence

Project "SIGUEMED" data sheet

The following table provides information about the project.

Coordinator	INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL Organization address address: AVENIDA DEL PAPA NEGRO 129 6F city: MADRID postcode: 28043 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-08-01 to 2020-01-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL Organization address address: AVENIDA DEL PAPA NEGRO 129 6F city: MADRID postcode: 28043 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	coordinator	50˙000.00

Map

Project objective

SIGUEMED is provides the first cost-effective and convenient solution to an unsolved world-wide problem of massive economic and societal impact: the non-adherence to medication of chronic poly-medicated patients. Low medical adherence represents a heavy burden for the EU28 in terms of: - Cost due to extra medical treatment that needs to be given and to additional hospitalisations: estimated at 125,000 M€/year. - Premature deaths that could be avoided with correct adherence to medication: over 200,00 citizens/year Currently there are several solutions that attempt to increase medication adherence, but none of them reaches a sufficient market penetration because they are not useful enough or do not fully meet user demands. To bridge that market gap, we have developed SIGUEMED. SIGUEMED is an IoT eHealth solution aimed at fostering and monitoring medical adherence in a disruptive way. By combining a smart personalized blister pack with printed circuits in its foil (key enabling technology), wearables connected via Bluetooth to the base dock and a SW platform, we are able to remind to the patients intake the time for the intake of pills, and to track if and when this intake has taken place. If there has been any breach in the intake, a cascade of alerts is sent to contact people (relatives, caretaker, pharmacists). Access to track records and monthly reports is also possible. SIGUEMED is especially user-friendly, even for digital immigrants. To commercialize SIGUEMED we will create a network of associated pharmacies, which will be our clients and will shape our network of authorized distributors. They will sale and provide SIGUEMED’s associate services to poly-medicated patients, which are the end-users. After five year of commercialization, we expect to have built a network of more than 10,000 pharmacies in 5 different EU countries and have reached more than 350,000 patients through them. The ROI of the project is of 3.80.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SIGUEMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SIGUEMED" are provided by the European Opendata Portal: CORDIS opendata.